Literature DB >> 10775110

Emergence of genetic instability in children treated for leukemia.

B A Finette1, A C Homans, R J Albertini.   

Abstract

T cells from patients who had received chemotherapy for B-lineage acute lymphocytic leukemia were studied to determine whether genetic instability, a principal characteristic of cancer cells, can also occur in nonmalignant cells. Consistent with expectations for a genetic instability phenotype, multiple mutations were detected in the hypoxanthine-guanine phosphoribosyltransferase (HPRT) reporter gene in independently isolated mutant T cells expressing identical rearranged T cell receptor beta (TCRbeta) gene hypervariable regions. These results indicate that cancer treatment can lead to genetic instability in nonmalignant cells in some individuals. They also suggest a mechanistic paradigm for the induction of second malignancies and drug resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775110     DOI: 10.1126/science.288.5465.514

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  10 in total

1.  Clusters of mutations from transient hypermutability.

Authors:  John W Drake; Anna Bebenek; Grace E Kissling; Shyamal Peddada
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 2.  Too many mutants with multiple mutations.

Authors:  John W Drake
Journal:  Crit Rev Biochem Mol Biol       Date:  2007 Jul-Aug       Impact factor: 8.250

3.  Genetic mechanisms of formation of radiation-induced instability of the genome and its transgenerational effects in the descendants of chronically irradiated individuals of Drosophila melanogaster.

Authors:  Elena Yushkova
Journal:  Radiat Environ Biophys       Date:  2020-02-19       Impact factor: 1.925

4.  High rate of mutation reporter gene inactivation during human T cell proliferation.

Authors:  Aida Gabdoulkhakova; Gunnel Henriksson; Nadezhda Avkhacheva; Alexander Sofin; Anders Bredberg
Journal:  Immunogenetics       Date:  2006-12-19       Impact factor: 2.846

5.  The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage.

Authors:  Lorel M Colgin; Alden F M Hackmann; Mary J Emond; Raymond J Monnat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 6.  Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.

Authors:  Noah A Kaitz; Cindy L Zuleger; Peng Yu; Michael A Newton; Richard J Albertini; Mark R Albertini
Journal:  Mutat Res Rev Mutat Res       Date:  2022-03-11       Impact factor: 7.015

7.  Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.

Authors:  Truc Nguyen; Pamela M Vacek; Patrick O'Neill; Richard B Colletti; Barry A Finette
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

8.  Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients.

Authors:  Mark R Albertini; Michael D Macklin; Cindy L Zuleger; Michael A Newton; Stephen A Judice; Richard J Albertini
Journal:  Environ Mol Mutagen       Date:  2008-12       Impact factor: 3.216

9.  Gene conversion in human genetic disease.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Genes (Basel)       Date:  2010-12-22       Impact factor: 4.096

Review 10.  The cell cycle checkpoint inhibitors in the treatment of leukemias.

Authors:  A Ghelli Luserna di Rora'; I Iacobucci; G Martinelli
Journal:  J Hematol Oncol       Date:  2017-03-29       Impact factor: 17.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.